Urinary Infection during Pregnancy: Case-Control Study in the Maternity Wards of the Teaching Hospitals of Yaoundé Cameroon
Henri Essome1,2, Moustapha Bilkissou1, Fulbert Mangala Nkwele1, Aurel Mbog Wetjeng1, Ingrid Doriane Ofakem Ilick1,2, Astrid Ndolo Kondo1,2, Merlin Boten Bounyom3, Michel Roger Ekono1, Alphonse Ngalame Nyong4, Robert Tchounzou4, Junie Ngaha Yaneu1, Marga Vanina Ngono Akam5, Gervais Mounchikpou Ngouhouo1, Grâce Tocki Toutou2*, Théophile Nana Njamen4, Valère Mve Koh5
1Training, Teaching and Research Unit in Gynecology Obstetrics and Reproduction, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
2Laquintinie Hospital, Douala, Cameroon.
3Faculty of Health Sciences, University of Bamenda, Bamenda, Cameroon.
4Faculty of Health Sciences, University of Buea, Buea, Cameroon.
5Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
DOI: 10.4236/ojog.2024.1411144   PDF    HTML   XML   81 Downloads   579 Views  

Abstract

Introduction: Acute pyelonephritis in pregnancy (APN) is a bacterial infection of the upper urinary tract (pyelitis) and renal parenchyma (nephritis), complicating or associated with an infection of the lower urinary tract. Objective: Study the clinical and para-clinical profile linked to their occurrence of APN during pregnancy in the city of Yaoundé. Methodology: This was a case-control analytical study lasting 07 months with retrospective data collection and covering a period of six years from January 2015 to December 2020 in 03 teaching hospitals in the city of Yaoundé. The data was recorded on a pre-tested technical sheet. We recruited the files of pregnant women in whom a urinary infection had been diagnosed using urine culture. The cases were the files of pregnant women with signs of APN and the controls were the files of pregnant women without signs of APN. The matching criteria were: recruitment site, age and term of pregnancy. Incomplete files were excluded. Statistical analyzes were carried out with Epi-Info 7 and Excel 2016 software. Statistical significance was set at a P value < 0.05. Results: We recruited: 55 cases and 110 controls. The factors associated with the occurrence of APN in pregnancy after logistic regression were: free union (OR: 2.19; P = 0.030), sexual intercourse during pregnancy (OR: 4.47; P = 0.001), positive HIV serology (OR: 5.52; P = 0.001), pre-gestational diabetes (OR: 10.9; P = 0.02) and a history of urinary infection during pregnancy (OR: 11.86; P = 0.001). Conclusion: Acute pyelonephritis in pregnancy is an uncommon but serious pathology. Its risk factors in our context are free union, sexual intercourse during pregnancy, positive HIV serology, pre-gestational diabetes, and a history of urinary infection during pregnancy.

Share and Cite:

Essome, H. , Bilkissou, M. , Nkwele, F. , Wetjeng, A. , Ilick, I. , Kondo, A. , Bounyom, M. , Ekono, M. , Nyong, A. , Tchounzou, R. , Yaneu, J. , Akam, M. , Ngouhouo, G. , Toutou, G. , Njamen, T. and Koh, V. (2024) Urinary Infection during Pregnancy: Case-Control Study in the Maternity Wards of the Teaching Hospitals of Yaoundé Cameroon. Open Journal of Obstetrics and Gynecology, 14, 1735-1756. doi: 10.4236/ojog.2024.1411144.

1. Introduction

Urinary infection (UI) corresponds to the attack on a tissue of the urinary tree by one or more microorganisms generating an inflammatory response, as well as signs and symptoms of variable nature and intensity depending on the background [1]. During pregnancy, it can manifest in several forms, the most serious of which is acute pyelonephritis of pregnancy (APN) [2] [3]. APN is a bacterial infection of the upper urinary tract (Pyelitis) and renal parenchyma (nephritis), complicating or associated with an infection of the lower urinary tract [4].

The annual incidence of APN worldwide is 10.5 to 25.9 million [5]. The number of deaths caused by it is estimated at 4000 per year [6]. The risk of ANP is increased during pregnancy due to anatomical and physiological changes in the urinary tract [7]. The frequency of ANP during pregnancy ranges from 0.5% to 2% worldwide. In Algeria, 0.3% of pregnant women were hospitalized for APN [8]; while Tchente et al. [9] reported a hospital prevalence of 0.6%. Several factors associated with the occurrence of APN have been found in the literature, notably sociodemographic and clinical factors. In California, black or Hispanic race, smoking, low education level and age less than 20 years were significantly associated with the occurrence of APN [10]. While in Jamaica, the age group between 20 and 29 was a risk factor [11]. Traore found that in Mali, the profession of housewife was significantly associated with the risk of occurrence of APN [12]. For some authors, the majority of APN occurred in the second trimester of pregnancy [11] [13]; on the other hand, for others, they frequently occurred in the third trimester [14]. Additionally, some studies found that nulliparity was a risk factor while others showed an inverse relationship between parity and APN [13] [15].

In Cameroon, few studies are available on this subject; for this reason, we proposed to conduct a case-control study in order to study the clinical and para-clinical profile linked to the occurrence of APN in the city of Yaoundé.

2. Materials and Methods

2.1. Type and Place of Study

We conducted a multicenter analytical case-control study with retrospective data collection in the maternity wards of three teaching hospitals in the city of Yaoundé (Centre Hospitalier et Universitaire de Yaoundé (CHUY), the Central Hospital of Yaoundé (CHY), and the Gyneco-Obstetric and Pediatric Hospital of Yaoundé (GOPHY).

2.2. Period and Duration of the Study

Our study covered a period of 06 years from January 1, 2015 to December 31, 2020 with data collection and duration of 7 months from January 2021 to July 2021.

2.3. Study Population

2.3.1. General Population

Was made up of all pregnant women monitored and/or hospitalized in the three hospitals selected for our study.

2.3.2. Target Population

It consisted of pregnant women in whom a urinary infection had been diagnosed by urine culture during our study period.

2.3.3. Inclusion Criteria

Inclusion criteria for cases: included in our study were the files of pregnant women in whom the diagnosis of APN had been made and who presented at admission:

  • A fever.

  • Pain when shaking a lumbar fossa (kidney Murphy punch positive).

  • A positive urine culture.

Inclusion criteria for controls: included in our study were the files of pregnant women followed for urinary infection (with positive urine culture) in the absence of signs of APN (fever and/or pain when shaking a lumbar fossa).

2.3.4. Exclusion Criteria

Exclusion criteria for cases: was excluded from our study:

  • Incomplete files.

  • Records of pregnant women presenting a differential diagnosis of APN such as: malaria, pulmonary infection, diverticular sigmoiditis, spondylodiscitis, psoas abscess or hematoma, and degenerative spinal pathology.

  • Records of pregnant women with comorbidities (postpartum hemorrhage, chorioamnionitis) that could lead to complications that can be confused with APN.

Exclusion criteria for controls: were excluded, incomplete files.

2.3.5. Matching Criteria

Cases and controls were matched according to: recruitment site, maternal age (±2 years), gestational age (±1 week) with a matching coefficient of one case for two controls.

2.3.6. Sampling

Our sampling was non-probabilistic based on the consecutive recruitment of files of pregnant women meeting the selection criteria. The calculation was done with the Schlesselman formula.

The minimum sample size required for this study was 48 participants in the case group and 96 participants in the control group, for a minimum total size of 144 pregnant women.

2.3.7. Procedure

Once research authorizations had been obtained, we began by examining the registers of the gyneco-obstetrics departments of the CHUY, CHY and GOPHY, in order to identify the patients who would be part of our study. These were pregnant women who were followed for urinary infections during our study period and who presented significant bacteriuria on the urine culture. We then went to the archives service to search for the files of these pregnant women. Information that we could not find in the files was obtained by telephone call. Based on our selection criteria, we chose the files that would be part of our study. We divided them into two groups: cases and controls.

2.3.8. Study Variables

The questionnaire made it possible to collect information on:

  • Sociodemographic variables.

  • Obstetric and gynecological history.

  • Pregnancy monitoring.

  • Symptoms, Parameters and Physical Signs on Admission.

  • Para-clinical results.

2.3.9. Statistical Analysis

The data were collected on a structured and pre-tested technical sheet conceived by Mve, Essome and Mbog, and data recorded and analyzed by Epi Info statistical computer software version 3.5.4. We used a 95% confidence interval, a margin of error α of 5%. Differences were considered statistically significant for values of P ≤ 0.05.

2.3.10. Ethical Considerations

Our study was previously submitted to the validation of the ethics and institutional committee of the University of Douala, with a view to obtaining ethical clearance. Authorizations for recruitment in the study sites were also obtained from the managers of the said hospitals.

3. Results

We used 236 files and retained 165 (Figure 1).

We recruited in three teaching hospitals affiliated with the Faculty of Medicine of the University of Yaoundé 1 and as follows: 18 cases and 36 controls at the CHY; 22 cases and 44 controls at CHUY; 15 cases and 30 controls GOPHY (Table 1).

Figure 1. Sociodemographic characteristics.

Table 1. Distribution of cases and controls by recruitment sites.

Case

Controls

Total

RECRUITMENT SITES

n = 55 (%)

n = 110 (%)

N = 165 (%)

CHY

18 (32.7)

36 (32.7)

54 (32.7)

CHUY

22 (40)

44 (40)

66 (40)

GOPHY

15 (27.3)

30 (27.3)

45 (27.3)

The average age was 26.7 ± 5.3 (16 - 38) in cases and 26.5 ± 4.9 (16 - 36) in controls.

The mean gestational age at admission was 26.95 ± 7.91 (6.28 - 36.42) in cases and 27.48 ± 7.51 (7.42 - 37.14) in controls (Table 2).

Cohabitation increased the risk of APN [OR: 2.19; 95% CI (1.03 - 4.62); P = 0.030] as opposed to age and level of education which were not associated with it (Table 3).

Table 2. Mean gestational age of cases and controls at admission.

Mean gestational age at admission

Mean

Standard deviation

Minimum

Maximum

Median

Mode

Case

26.9558

7.9171

6.2857

36.4286

29.1429

35.4286

Controls

27.4857

7.5179

7.4286

37.1429

29

32.2857

Table 3. Correlation between age, marital status, level of education, and the occurrence of APN.

Variables

Case n = 55 (%)

Control n = 110 (%)

Total N = 165 (%)

OR (95% CI)

P-value

Age

<20

4 (7.3)

8 (7.3)

12 (7.3)

1 (0.25 - 3.47)

0.610

[20 - 25]

18 (32.7)

34 (30.9)

52 (31.5)

1.09 (0.54 - 2.17)

0.470

[25 - 30]

14 (25.5)

32 (29.1)

46 (27.9)

0.83 (0.39 - 1.73)

0.380

[30 - 35]

15 (27.3)

32 (29.1)

47 (28.5)

0.91 (0.44 - 1.88)

0.480

[35 - 40]

4 (7.3)

4 (3.6)

8 (4.8)

2.08 (0.45 - 9.51)

0.250

Marital Status

Married

18 (32.7)

45 (40.9)

63 (38.2)

0.7 (0.35 - 1.39)

0.200

Single

19 (34.5)

43 (39.1)

62 (37.6)

0.82 (0.41 - 1.62)

0.350

Divorced

0 (0)

2 (1.8)

2 (1.2)

0 (0 - 6.95)

0.440

Free Union

18 (32.7)

20 (18.2)

38 (23)

2.19 (1.03 - 4.62)

0.030*

Level of study

Not scolarised

5 (9.1)

6 (5.5)

11 (6.7)

1.73 (0.46 - 6.2)

0.280

Primary

5 (9.1)

9 (8.2)

14 (8.5)

1.12 (0.33 - 3.53)

0.530

Secondary

24 (43.6)

43 (39.1)

67 (40.6)

1.21 (0.62 - 2.33)

0.350

Higher education

21 (38.2)

52 (47.3)

73 (44.2)

0.69 (0.35 - 1.34)

0.170

* is for figures with statistical significance (the same as in the following tables).

Having sexual intercourse during pregnancy increased the risk of occurrence of APN [OR: 54.47; 95% CI (142.31 - 340.86); P = 0.01 as much as pre-gestational diabetes [OR: 10.9; 95% CI (1.44 - 261.43); P = 0.020] (Table 4 and Table 5). However, there was no correlation between the trimester of pregnancy at admission and the occurrence of APN (Table 6).

Table 4. Correlation between reproductive characteristics and the occurrence of APN.

Case

Control

Total

Variables

n = 55 (%)

n = 110 (%)

N = 165 (%)

OR (95% CI)

P-value

Gravidity

Primigravid

18 (32.7)

24 (21.8)

42 (25.5)

1.74 (0.83 - 3.6)

0.090

Paucigravid

13 (23.6)

28 (25.5)

41 (24.8)

0.91 (0.42 - 1.92)

0.480

Multigravid

16 (29.1)

37 (33.6)

53 (32.1)

0.81 (0.39 - 1.63)

0.340

Grand Multigravid

8 (14.5)

21 (19.1)

29 (17.6)

0.72 (0.28 - 1.73)

0.310

Parity

Nulliparous

22 (40)

42 (38.2)

64 (38.8)

1.08 (0.55 - 2.1)

0.480

Primiparous

15 (27.3)

25 (22.7)

40 (24.2)

1.28 (0.6 - 2.68)

0.320

Pauciparou

6 (10.9)

20 (18.2)

26 (15.8)

0.55 (0.19 - 1.43)

0.160

Multiparous

6 (10.9)

18 (16.4)

24 (14.5)

0.63 (0.22 - 1.65)

0.240

Grand Multipara

6 (10.9)

5 (4.5)

11 (6.7)

2.57 (0.71 - 9.51)

0.110

Sex during pregnancy

Yes

53 (96.4)

36 (32.7)

89 (53.9)

54.47 (14.31 - 340.86)

0.001*

No

2 (3.6)

74 (67.3)

76 (46.1)

Table 5. Correlation between medical history and occurrence of APN.

Medical history

Case

n = 55 (%)

Control n = 110 (%)

Total N = 165 (%)

OR (95% CI)

P-value

HTN

Yes

2 (3.6)

1 (0.9)

3 (1.8)

4.11 (0.3 - 122.33)

0.260

No

53 (96.4)

109 (99.1)

162 (98.2)

Diabetes

Yes

5 (9.1)

1 (0.9)

6 (3.6)

10.9 (1.44 - 261.43)

0.020*

No

50 (90.9)

109 (99.1)

159 (96.4)

Sickle cell anemia

Yes

1 (1.8)

0 (0)

1 (0.6)

Undefined

0.330

No

54 (98.2)

110 (100)

164 (99.4)

Others

Yes

20 (36.4)

15 (13.6)

35 (21.2)

3.62 (1.65 - 7.92)

0.110

No

35 (63.6)

95 (86.4)

130 (78.8)

Table 6. Correlation between the trimester of pregnancy at admission and the occurrence of APN.

Trimester on admission

Case n = 55 (%)

Control n = 110 (%)

Total

N = 165 (%)

OR (95% CI)

P-value

1st Trimester

5 (9.1)

9 (8.2)

14 (8.5)

1.12 (0.33 - 3.53)

0.530

2nd Trimester

20 (36.4)

39 (35.5)

59 (35.8)

1.04 (0.52 - 2.04)

0.520

3rd Trimester

30 (54.5)

62 (56.4)

92 (55.8)

0.93 (0.48 - 1.79)

0.480

On the other hand, having had your first ANC after 15 weeks increased the risk of occurrence of APN by three times. [OR: 3.19; 95% CI (1.52 - 6.67); P = 0.001] while having done it before 15 weeks was a protective factor.

Having ANC in a district hospital increased the risk of occurrence of APN [OR: 7.4; 95% CI (2.3 - 27.49); P = 0.001]. Whereas, doing your ANC in a first category hospital was a protective factor.

Having your pregnancy monitored by a midwife/nurse increased the risk of occurrence of ANC [OR: 6.07; 95% CI (1.57 - 29.03); P = 0.01]. On the other hand, being followed by a gynecologist was a protective factor (Table 7).

Table 7. Correlation between the characteristics of ANC and the occurrence of APN.

Variables

Case

n = 55 (%)

Control n = 110 (%)

Total N = 165 (%)

OR (95% CI)

P-value

Number of ANC

<4

37 (67.3)

63 (57.3)

100 (60.6)

1.53 (0.78 - 3.06)

0.140

[4 - 7]

17 (30.9)

47 (42.7)

64 (38.8)

0.6 (0.3 - 1.19)

0.100

> 7

1 (1.8)

1 (0.9)

2 (1.2)

2.02 (0.05 - 79.39)

0.560

Gestational age at first ANC

≤15 SA

23 (41.8)

83 (75.5)

106 (64.2)

0.23 (0.12 - 0.47)

0.001*

>15 SA

22 (40)

19 (17.3)

41 (24.8)

3.19 (1.52 - 6.67)

0.001*

ANC location

1st category hospital

20 (36.4)

64 (58.2)

84 (50.9)

0.41 (0.21 - 0.8)

0.010*

2nd category hospital

12 (21.8)

30 (27.3)

42 (25.5)

0.74 (0.34 - 1.59)

0.290

District hospital

12 (21.8)

4 (3.6)

16 (9.7)

7.4 (2.3 - 27.49)

0.001*

Medical Center

3 (5.5)

0 (0)

3 (1.8)

undefined

0.040

Health center

8 (14.5)

12 (10.9)

20 (12.1)

1.39 (0.51 - 3.65)

0.330

ANC provider

Gynecologist

36 (65.5)

94 (85.5)

130 (78.8)

0.32 (0.15 - 0.7)

0.001*

General practitioner

11 (20)

13 (11.8)

24 (14.5)

1.87 (0.75 - 4.53)

0.120

Mid-wife/nurse

8 (14.5)

3 (2.7)

11 (6.7)

6.07 (1.57 - 29.03)

0.010*

Pregnant women who had a genital infection during pregnancy had a 10 times higher risk of developing APN [OR: 9.94 95% CI (3.2 - 36.1); P = 0.001]. Having had a urinary infection during pregnancy increased the risk of developing APN [OR; 11.86 95% CI (3.87 - 42.6); P = 0.001]. Gestational diabetes increased the risk of occurrence of APN [OR; 5.37 95% CI (1.91 - 16.06); P = 0.001] (Table 8).

Table 8. Correlation between maternal pathologies during pregnancy and the occurrence of APN.

Pathologies during pregnancy

Case n = 55 (%)

Control n = 110 (%)

Total N = 165 (%)

OR (95% CI)

P-value

Threatened premature delivery

Yes

1 (1.8)

4 (3.6)

5 (3)

0.49 (0.02 - 4.03)

0.460

No

54 (98.2)

106 (96.4)

160 (97)

Threatened abortion

Yes

12 (21.8)

18 (16.4)

30 (18.2)

1.43 (0.61 - 3.23)

0.260

No

43 (78.2)

92 (83.6)

135 (81.8)

Genital infection Yes

15 (27.3)

4 (3.6)

19 (11.5)

9.94 (3.2 - 36.1)

0.001*

No

40 (72.7)

106 (96.4)

146 (88.5)

Urinary infection

Yes

17 (30.9)

4 (3.6)

21 (12.7)

11.86 (3.87 - 42.6)

0.001*

No

38 (69.1)

106 (96.4)

144 (87.3)

Malaria

Yes

14 (25.5)

25 (22.7)

39 (23.6)

1.16 (0.54 - 2.46)

0.420

No

41 (74.5)

85 (77.3)

126 (76.4)

Gestational Diabetes

Yes

13 (23.6)

6 (5.5)

19 (11.5)

5.37 (1.91 - 16.06)

0.001*

No

42 (76.4)

104 (94.5)

146 (88.5)

HTN

Yes

1 (1.8)

4 (3.6)

5 (3)

0.49 (0.02 - 4.03)

0.460

No

54 (98.2)

106 (96.4)

160 (97)

In pregnant women with a urinary infection, the occurrence of fever, chills, lumbar pain, urinary burn and asthenia was significantly similar to APN (Table 9).

Table 9. Correlation between symptoms on admission and the occurrence of APN.

Reason for consultation

Case n = 55 (%)

Control n = 110 (%)

Total N = 165 (%)

OR (95% CI)

P-value

Fever

Yes

53 (96.4)

1 (0.9)

54 (32.7)

2888.5 (270.75 - 58356)

0.001*

No

2 (3.6)

109 (99.1)

111 (67.3)

Chills

Yes

31 (56.4)

1 (0.9)

32 (19.4)

140.79 (23.97 - 2920.9)

0.001*

No

24 (43.6)

109 (99.1)

133 (80.6)

Nausea

Yes

3 (5.5)

9 (8.2)

12 (7.3)

0.65 (0.14 - 2.41)

0.390

No

52 (94.5)

101 (91.8)

153 (92.7)

Pelvic Pain

Yes

19 (34.5)

47 (42.7)

66 (40)

0.71 (0.36 - 1.39)

0.200

No

36 (65.5)

63 (57.3)

99 (60)

Vomitting

Yes

4 (7.3)

13 (11.8)

17 (10.3)

0.59 (0.16 - 1.83)

0.270

No

51 (92.7)

97 (88.2)

148 (89.7)

Lumbar pain

Yes

27 (49.1)

0 (0)

27 (16.4)

undefined

0.001*

No

28 (50.9)

110 (100)

138 (83.6)

Urinary burn

Yes

5 (9.1)

68 (61.8)

73 (44.2)

0.06 (0.02 - 0.16)

0.001*

No

50 (90.9)

42 (38.2)

92 (55.8)

Asthenia

Yes

33 (60)

15 (13.6)

48 (29.1)

9.5 (4.38 - 20.6)

0.001*

No

22 (40)

95 (86.4)

117 (70.9)

Pollakiuria

Yes

37 (67.3)

81 (73.6)

118 (71.5)

0.74 (0.36 - 1.51)

0.250

No

18 (32.7)

29 (26.4)

47 (28.5)

Other Symptoms

Yes

14 (25.5)

25 (22.7)

39 (23.6)

1.16 (0.54 - 2.46)

0.420

No

41 (74.5)

85 (77.3)

126 (76.4)

In pregnant women with a urinary infection:

A normal temperature on admission was a protective factor for APN. A Heart Rate > 100 bpm [OR: 42.25; 95% CI (15.48 - 121.08); P = 0.001] and a FR > 20 cpm [OR: 4.85; 95% CI (2.34 - 10.25); P = 0.001] increased the risk of occurrence of APN. Fetal tachycardia increased the risk of finding APN [OR: 4.92; 95% CI (4.92 - 133.33); P = 0.001]. A normal fetal heart rate was a protective factor (Table 10).

Table 10. Correlation between vital parameters on admission and the occurrence of APN.

Variables

Case

n = 55 (%)

Control

n = 110 (%)

Total

N = 165 (%)

OR (95% CI)

P-value

Temperature

[36˚ - 38.5˚]

3 (5.5)

29 (26.4)

32 (19.4)

0.16 (0.04 - 0.51)

0.001*

>38.5˚

52 (94.5)

0 (0)

52 (31.5)

/

0.001

Heart rate

≤100

16 (29.1)

104 (94.5)

120 (72.7)

0.02 (0.01 - 0.06)

0.001*

>100

39 (70.9)

6 (5.5)

45 (27.3)

42.25 (15.48 - 121.08)

0.001*

Respiratory rate

≤20 cpm

13 (23.6)

66 (60)

79 (47.9)

0.21 (0.1 - 0.43)

0.001*

>20 cpm

42 (76.4)

44 (40)

86 (52.1)

4.85 (2.34 - 10.25)

0.001*

Systolic BP

<90

1 (1.8)

0 (0)

1 (0.6)

/

0.330

[90 - 139]

52 (94.5)

107 (97.3)

159 (96.4)

0.49 (0.08 - 2.93)

0.320

[140 - 159]

0 (0)

2 (1.8)

2 (1.2)

0 (0 - 6.95)

0.440

[160 - 179]

2 (3.6)

1 (0.9)

3 (1.8)

4.11 (0.3 - 122.33)

0.260

Diastolic BP

<60

4 (7.3)

4 (3.6)

8 (4.8)

2.08 (0.45 - 9.51)

0.250

[60 - 89]

49 (89.1)

103 (93.6)

152 (92.1)

0.56 (0.17 - 1.85)

0.230

[90 - 99]

1 (1.8)

3 (2.7)

4 (2.4)

0.66 (0.02 - 6.36)

0.590

[100 - 109]

1 (1.8)

0 (0)

1 (0.6)

Undefined

0.330

FHR

<120

0 (0)

1 (0.9)

1 (0.6)

0 (0 - 38)

0.670

[120 - 160]

28 (50.9)

85 (77.3)

113 (68.5)

0.31 (0.15 - 0.61)

0.001*

>160

15 (27.3)

2 (1.8)

17 (10.3)

20.25 (4.92 - 133.33)

0.001*

In pregnant women with a urinary infection:

Altered general state increased the risk of occurrence of APN [OR: 23.82; 95% CI (9.35 - 63.4); P = 0.001]. The Giordano sign was positive in 67.3% of cases on the right and in 32.7% of cases on the left. When they were in labor on admission, the risk of finding APN was increased [OR: 27.25; 95% CI (4.37 - 59.64); P = 0.001] (Table 11).

Table 11. Correlation between physical examination findings and occurrence of APN.

Physical Signs

Case

n = 55 (%)

Control

n = 110 (%)

Total

N = 165 (%)

OR (95% CI)

P-value

Altered general state

Yes

34 (61.8)

7 (6.4)

41 (24.8)

23.82 (9.35 - 63.4)

0.001*

No

21 (38.2)

103 (93.6)

124 (75.2)

Lumbar shaking pain

Yes

55 (100)

0 (0)

55 (33.3)

Undefined

0.001*

No

0 (0)

110 (100)

110 (66.7)

Patient in labor on admission

Yes

11 (20)

1 (0.9)

12 (7.3)

27.25 (4.37 - 596.47)

0.001*

No

44 (80)

109 (99.1)

153 (92.7)

We found no correlation between the organisms isolated at urine culture and the occurrence of APN. The germs most encountered in our population were:

  • Escherichia coli: 52.7% in cases and controls.

  • Proteus mirabilis: 21.8% in cases and 23.6% in controls.

Klebsiella pneumoniae: 12.7% in cases, and 10.9% in controls (Table 12).

Table 12. Correlation between germs isolated at urine culture and the occurrence of APN.

Case

Control

Total

OR (95% CI)

P-value

Urine culture

n = 55 (%)

n = 110 (%)

N = 165 (%)

E coli

Yes

29 (52.7)

58 (52.7)

87 (52.7)

1 (0.52 - 1.92)

0.570

No

26 (47.3)

52 (47.3)

78 (47.3)

Klebsiella P

Yes

7 (12.7)

12 (10.9)

19 (11.5)

1.19 (0.42 - 3.22)

0.460

No

48 (87.3)

98 (89.1)

146 (88.5)

Proteus Mirabilis

Yes

12 (21.8)

26 (23.6)

38 (23)

0.9 (0.4 - 1.95)

0.480

No

43 (78.2)

84 (76.4)

127 (77)

Other Germ

Yes

7 (12.7)

13 (11.8)

20 (12.1)

1.09 (0.38 - 2.9)

0.520

No

48 (87.3)

97 (88.2)

145 (87.9)

4. Discussion

Sociodemographic characteristics

The latter being regularly reported in the literature as significantly associated with the occurrence of APN, they have been particularly studied.

Maternal age

The average maternal age was 26.7 ± 5.3 in the cases with extremes of 16 and 38 years. A look at studies carried out in the same geographical context would have given us more information on this. We unfortunately did not see any. However, our results are in agreement with the findings of Farkash et al. in Israel in 2012 where the average age of onset of APN was 26.3 ± 6.0 years [16]. Other authors such as Gang Jee Ko et al., on the other hand, have reported average ages higher or even lower than that of our study. In 2020, 31 ± 4 years for Gang Jee ko in a global cohort, while in Nepal and Texas, the average maternal ages were 22 ± 3.41 and 23.1 ± 5.1 years respectively [13] [17]. Unlike other authors such as Wing et al., we did not find a correlation between maternal age and the occurrence of APN. This data is found differently among all the authors we consulted. For Wing in California, women under 20 were more likely to have APN (OR = 2.0; CI = 95%, 1.8 - 2.3) [9]; while Dawkins and Sharma the age range between 20 to 29 years is significantly associated with the risk of APN [11] [13].

Level of education

In contradiction with literature data, we found no correlation between educational level and the occurrence of APN. However, some authors have dealt with this association in the literature, such as Wing et al., who found that compared to women who had 13 years of formal education, women who had only 12 years of education or less had a significantly increased risk of acute pyelonephritis (OR: 1.3; 95% CI: 1.2 - 1.5) [10]. Several other studies have found associations with low levels of education [18]-[20]. On the other hand, following Tchente et al., the high level of education was protective: primary level (P = 0.037; OR = 0.088; CI = 0.009 - 0.872) secondary level (P = 0.036; OR = 0.113; CI = 0.015 - 0.874) and university level (P = 0.03; OR = 0.106; CI = 0.014 - 0.81).

Marital status

This variable is variously reported by different authors regarding their association with APN. In our study we found that free union increased the risk of occurrence of APN [OR: 2.19; 95% CI (1.03 - 4.62); P = 0.030]. However, Labi et al. in their series found no link between marital status and APN [21]. Unlike Scholes in a case control study carried out in Washington which found an association between being single and the significant risk of having an APN [OR: 1.4; 95% CI (1.0 - 1.8); P = 0.005] [22].

Clinical factors associated with APN

Parity

Like Tchente, we found no correlation between parity and the occurrence of APN [8]. However, from the work of Western authors, it appears that nulliparity increased the risk of occurrence of APN like Wing et al. who found that nulliparity was significantly associated with the risk of developing APN and represented 48.6% cases [10]. As did Hill and Farkash who reported that nulliparity represented 50% to 75% of cases of APN in their respective series [16] [18].

For some, however, primiparity increased the risk of developing APN (OR [95% CI] 1.61 [1.55 - 1.67]) [17]. It should be noted that the average age of the pregnant women in these studies varied from 18 to 23 years; which is lower than the average age of our study which was 26 years and that of Tchente et al. which was 28 years.

Sexual intercourse

In our series, we found a correlation between sexual intercourse during pregnancy and the occurrence of APN (OR [95% CI] 54.47 [14.31 - 340.86]). These findings are in agreement with those of several authors in the literature including Fatton, Bethel, as well as Scholes et al. who described a link between sexual intercourse during pregnancy and APN [22]-[24]. Unlike Michel-Claire in a series in Clermont-Ferrand for whom no link existed between these two entities [25].

The term of pregnancy

This data is reported differently by the literature consulted about. In our series, the mean gestational age at admission was 26.9 ± 7.9 weeks of amenorrhea (WA) in cases with extremes of 6 and 36 weeks, close to 27.7 ± 7.4 weeks in Saleh’s series [26]. But higher than the 22 ± 7.8 and 24.1 ± 4.7 WA found in the Dawkins and Zanatta studies; and lower than the 37.8 ± 6 found in Israel [11] [16] [27]. In our series, APN occurred in 90.9% of cases in the last two trimesters; this result is in line with the data in the literature because the authors agree on the fact that APN occurs most of the time during the last two trimesters of pregnancy; these two quarters also represent 90.8%, 90%, 88.5% of cases for some [10] [13] [28]; and 79% of cases for others [18]. These results can be explained by the presence of certain hormonal and mechanical factors which predispose the pregnant woman to APN during the second half of pregnancy.

Prenatal follow-up

In our series, late initiation of ANC was weakly associated with the occurrence of APN while starting ANC before 15 weeks was a protective factor. The same goes for the Californian authors who, in an 18-year retrospective series, found that late initiation of prenatal visits increased the risk of having APN by 1.1 times (OR [95% CI] 1.4 [1.3 - 1.5]) [10].

Diabetes mellitus

Diabetes is the bedrock of infections; this assertion is accepted by all [29] [30]. But in our series, we did not find an association between this metabolic disorder and the occurrence of APN; as much as Farkash reported in his series in Iran (P = 0.45) [15]. Pre-gestational diabetes, however, increased the risk of occurrence of APN (OR [95% CI] 10.9 [1.44 - 261.43]). Wing et al. confirmed this in their 18-year retrospective series where pre-gestational diabetes increased the risk of occurrence of APN by 1.7 times (95% CI, 1.3 - 2.1) [10]. Ditto for Hill et al. who, in Texas, pre-gestational diabetes mellitus increased the risk of having APN in the first trimester of pregnancy (P = 0.013) [15] While other authors like Dawkins, found no association between diabetes mellitus and the occurrence of serious urinary infections in pregnancy [11].

History of urinary infection

In our study, a history of urinary infection during pregnancy emerged as a risk factor for APN (OR [95% CI] 11.86 [3.87 - 42.6]). Similar results are reported by Farkash (P = 0.001; OR = 10.3; CI = 4.8 - 22.1) [16]; as well as by Gang jee ko in South Korea [17].

HIV infection

HIV infection in our series with its deleterious effects on immune defense predisposed to a higher risk of developing APN (OR [95% CI] 5.52 [2.09 - 15.28]). This result is in agreement with data from the relevant international literature [31] [32]. The associated reduction in the immune system in addition, 20% to 30% of affected women may develop acute pyelonephritis [16].

5. Conclusion

At the end of this research work, the objective of which was to study the factors associated with the occurrence of APM during pregnancy in three hospitals in the city of Yaoundé, it emerged that: free union, sexual intercourse during pregnancy, positive HIV serology, pre-gestational diabetes and a history of urinary infection during pregnancy were significantly associated with the occurrence of APN in pregnancy in Yaoundé.

6. Limitations of the Study

The retrospective nature of our study imposes a certain number of inadequacies compared to that of the different authors, in particular the quality of the urine sample which was taken from pregnant women. Compared to those of other authors, the small size of our series, due to the deterioration of the files, could constitute a bias on our results due to a lack of statistical power.

Contribution to Science

Our study sheds light on this unexplored theme in our environment while opening the prospect of subsequent studies thus making it possible to develop operational strategies for prevention and early management of this condition with formidable impact for the mother and child.

Acknowledgements

Our gratitude to the hospital authorities as well as the various staff of these structures both for the authorizations and for the multifaceted supervision without which this retrospective study would not have been effective.

Contribution of the Authors

Essome and Mve supervised the study and writing of the manuscript, Mbog collected the data and wrote the manuscript, Tocki ensured the translation of the manuscript into English, as well as its formatting, Moustapha, Boten, Ofakem Ilick, Ndolo, Mangala, Ekono, Ngalame, Tchounzou, Ngaha, Ngono, Mounchikpou, Nana read and corrected the manuscript.

All authors have read and approved the final version.

Appendix: Survey Sheet

THEME: Factors associated with the occurrence of acute pyelonephritis in pregnancy in three hospitals in the city of Yaoundé.

INVESTIGATION SHEET NO.

CODIFICATION:

TELEPHONE:

DATE OF RECRUTMENT:

Indicator

Reponses

SECTION 1: CARACTERISTIQUES SOCIO-DEMOGRAPHIQUES

S1Q1

Age (in years)

S1Q2

Group

1-Cases

2-Controls

S1Q3

Hospital

1-CHUY

2-CHY

3-GOPHY

S1Q4

Profession

1-Public sector

2-Private sector

3-Pupil/Student

4-Trade

5-Housewife

6-Farmer

S1Q5

Level of education

1-Not scolarised

2-Primary

3-Secondary

4-Higher education

S1Q6

Marital status

1-Married

2-Single

3-Divorced

4-Widow(er)

5-Free uniom

S1Q7

Religion

1-Catholic

2-Protestant

3-Muslim

4-Jehovah witness

5-Others

S1Q8

If other religion, precise:

S1Q9

Region of origin

1-Far north

2-North

3-Adamawa

4-Centre

5-South

6-West

7 East

8-South West

9-North-west

10-Littoral

SECTION 2: OBSTETRICAL ET GYNECOLOGICAL HISTORY

S2Q1

Gestation

S2Q2

Parity

S2Q3

Number of prematures

S2Q4

If prematurity, last event dates back to how many months:

S2Q5

Number of abortions

S2Q6

If abortion, last event dates back to how many months:

S2Q7

Number of live children

S2Q8

Number of sexual partners

SECTION3: FOLLOW UP OF CURRENT PREGNANCY

S3Q1

Gestational age on admission

S3Q2

ANC realised

1 = yes 2 = no

S3Q3

If yes, number of ANC realised

S3Q4

Age at first ANC

S3Q5

Hospital where pregnancy is followed up:

1-1st category hospital

2-2nd category hospital

3-Regional hospital

4-District hospital

5-District medical center

6-Integrated health center

7-Private clinic

S3Q6

Pregnancy followed by:

1-Obstetrician-gynecologist

2-General practitioner

3-Midwife

4-Nurse

S3Q7

Multiple pregnancy:

1 = yes 2 = no

S3Q8

If yes, number of fetuses:

S3Q9

Macrosomia

1 = yes 2 = no

S3Q10

Hydramnios

1 = yes 2 = no

S3Q11

HIV

1-Positive

2-Negative

3-Not available

S3Q12

Hbs Ag

1-Positive

2-Negative

3-Not available

S3Q13

HCV Ab

1-Positive

2-Negative

3-Not available

S3Q14

Toxoplasmosis

1-Positive

2-Negative

3-Not available

S3Q15

Rubella

1-Positive

2-Negative

3-Not available

S3Q16

Syphilis

1-Positive

2-Negative

3-Not available

Maternal pathologies in pregnancy:

S3Q17

Threatened premamture delivery

1 = yes 2 = no

S3Q18

Threatened abortion

1 = yes 2 = no

S3Q19

Genital infection

1 = yes 2 = no

S3Q20

Urinary infection

1 = yes 2 = no

S3Q21

Malaria

1 = yes 2 = no

S3Q22

Gestational diabetis

1 = yes 2 = no

S3Q23

HTN

1 = yes 2 = no

S3Q24

Other pathology:

1 = yes 2 = no

S3Q25

If other, which one:

SECTION4: MEDICAL HISTORY

S4Q1

HTN

1 = yes 2 = no

S4Q2

Diabetis

1 = yes 2 = no

S4Q3

Sickle cell

1 = yes 2 = no

S4Q6

Other medical history

1 = yes 2 = no

S4Q7

If yes, precise:

SECTION5: SYMPTOMS ON ADMISSION

S5Q1

Fever

1 = yes 2 = no

S5Q2

Chills

1 = yes 2 = no

S5Q3

Asthenia

1 = yes 2 = no

S5Q4

Anorexia

1 = yes 2 = no

S5Q5

Nausea

1 = yes 2 = no

S5Q6

Vomitting

1 = yes 2 = no

S5Q7

Lumbar pain

1 = yes 2 = no

S5Q8

Lombo-pelvic pain similar to uterine contractions

1 = yes 2 = no

S5Q9

Dysuria

1 = yes 2 = no

S5Q10

Urianry burn

1 = yes 2 = no

S5Q11

Pollakuria

1 = yes 2 = no

S5Q12

Others:

1 = yes 2 = no

S5Q13

If others precise:

SECTION6: PARAMETERS ON ADMISSION

S6Q1

Temperature

S6Q2

Hr

S6Q3

RR

S6Q4

BP

S6Q5

Glycemia

S6Q6

BMI

1-Underweight (<18.5)

2-Normal (18.5 to 24.9)

3-Overweight (25 to 29.9)

4-Obese (≥30)

SECTION7: PHYSICAL SIGNS ON ADMISSION

S7Q1

Altered general state

1 = yes 2 = no

S7Q2

Lumbar shaking pain

1 = yes 2 = no

S7Q3

If yes, wich lumbar fossa:

1-Right

2-Left

3-Bilateral

S7Q4

Fundal height:

S7Q5

FHR

S7Q6

Presence of fetal movements

1 = yes 2 = no

S7Q7

Patient in labor

1 = yes 2 = no

S7Q8

If yes,

1-Active phase

2-Latent phase

SECTION8: PARACLINICAL

S8Q1

Isolated germ at urine culture

1-Escherichia coli

2-Klebsiella

3-Proteus mirabilis

4-Other

S8Q2

If other, precise

S8Q3

FBC realised:

1 = yes 2 = no

If yes:

S8Q4

Hemoglobine:

S8Q5

WBC:

S8Q6

Platelets:

S8Q7

CRP realised:

1 = yes 2 = no

S8Q8

If yes, the value:

S8Q9

Hemoculture realised:

1 = yes 2 = no

S8Q10

If realised:

1-Positive

2-Negative

S8Q11

If positive, isolated germ

1-Escherichia coli

2-Klebsiella

3-Proteus mirabilis

4-Autre

S8Q12

If other, precise:

S8Q13

Abdominal echography realised

1 = yes 2 = no

S8Q14

If yes, APN confirmed:

1 = yes 2 = no

S8Q15

Obstetrical echography realised during hospitalisation:

1 = yes 2 = no

Fœtal complications identified:

S8Q16

Acute fœtal distress

1 = yes 2 = no

S8Q17

Intra-uterine growth retardation

1 = yes 2 = no

S8Q18

Intra-uterine death

1 = yes 2 = no

S8Q19

Others:

1 = yes 2 = no

S8Q20

If others, precise:

SECTION9: MANAGEMENT

Antibiotics used:

S9Q1

Penicillines

1 = yes 2 = no

S9Q2

Cephalosporines

1 = yes 2 = no

S9Q3

Macrolides

1 = yes 2 = no

S9Q4

Aminosides

1 = yes 2 = no

S9Q5

Autres

1 = yes 2 = no

S9Q6

If others, precise:

S9Q7

Parenteral treatment

1 = yes 2 = no

S9Q8

If yes, duration (in days):

S9Q9

Enteral treatment

1 = yes 2 = no

S9Q10

If yes, duration (in days):

S9Q11

Hospitalisation:

1 = yes 2 = no

S9Q12

If yes, duration (in days):

S9Q13

Progress during hospitalisation

1-Favorable

2-Complicated

S9Q14

Surgical drainage

1 = yes 2 = no

SECTION10: COMPLICATIONS MATERNELLES

S10Q1

Preeclampsia

1 = yes 2 = no

S10Q2

Anemia

1 = yes 2 = no

S10Q3

Premature delivery

1 = yes 2 = no

S10Q4

Septic shock

1 = yes 2 = no

S10Q5

Acute renal failure

1 = yes 2 = no

S10Q6

Death

1 = yes 2 = no

S10Q7

Others:

S10Q8

If others precise:

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Bruyère, F., Cariou, G., Boiteux, J., Hoznek, A., Mignard, J., Escaravage, L., et al. (2008) Pyélonéphrites Aiguës. Progrès en Urologie, 18, 14-18.[CrossRef] [PubMed]
[2] Fournié, A., Jalle, T., Sentilhes, L. and Lefebvre-Lacœuille, C. (2008) Infections urinaires chez la femme enceinte. EMCObstétrique, 3, 1-8.[CrossRef
[3] Caron, F. and Galperine, T. (2015) Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l’adulte: Spilf.
https://www.infectiologie.com/UserFiles/File/spilf/recos/infections-urinaires-spilf.pdf
[4] Drai, J., Bessede, T. and Patard, J. (2012) Prise en charge des pyélonéphrites aiguës. Progrès en Urologie, 22, 871-875.[CrossRef] [PubMed]
[5] Czaja, C.A., Scholes, D., Hooton, T.M. and Stamm, W.E. (2007) Population-Based Epidemiologic Analysis of Acute Pyelonephritis. Clinical Infectious Diseases, 45, 273-280.[CrossRef] [PubMed]
[6] Lagu, T., Rothberg, M.B., Shieh, M., Pekow, P.S., Steingrub, J.S. and Lindenauer, P.K. (2012) Hospitalizations, Costs, and Outcomes of Severe Sepsis in the United States 2003 to 2007. Critical Care Medicine, 40, 754-761.[CrossRef] [PubMed]
[7] Maria, M.B. (2017) Pyélonéphrite gravidique: Causes et consequences. Thèse de Médecine, Université de sidi mohamed ben abdellah, N0243.
[8] Loh, K. and Sivalingam, N. (2007) Urinary Tract Infections in Pregnancy. Malaysian Family Physicians, 2, 54-57.
[9] Wing, D.A., Fassett, M.J. and Getahun, D. (2014) Acute Pyelonephritis in Pregnancy: An 18-Year Retrospective Analysis. American Journal of Obstetrics and Gynecology, 210, 219.e1-219.e6.[CrossRef] [PubMed]
[10] Dawkins, J.C., Fletcher, H.M., Rattray, C.A., Reid, M. and Gordon-Strachan, G. (2012) Acute Pyelonephritis in Pregnancy: A Retrospective Descriptive Hospital Based-Study. ISRN Obstetrics and Gynecology, 2012, Article ID: 519321.[CrossRef] [PubMed]
[11] Traore, S. (2017) La pyélonéphrite sur la grossesse dans le service de gynécologie obstétrique du CSREF: À propos de 28 cas. Thèse de Médecine, Université de Bamako, N0243.
[12] Sharma, P. and Thapa, L. (2007) Acute Pyelonephritis in Pregnancy: A Retrospective Study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 47, 313-315.[CrossRef] [PubMed]
[13] Medkour, Z.S., Mohammed Cherif, A. and Tolba, M. (2020) Etude statistique de quelques cas de pyélonéphrite gravidique (PNA) et son impact sur la santé des femmes enceintes.
https://theses-algerie.com/1282317837263883/memoire-de-master/universite-larbi-ben-m-hidi---om-el-bouaghi
[14] Gilstrap, L.C. and Ramin, S.M. (2001) Urinary Tract Infections during Pregnancy. Obstetrics and Gynecology Clinics of North America, 28, 581-591.[CrossRef] [PubMed]
[15] Farkash, E., Weintraub, A.Y., Sergienko, R., Wiznitzer, A., Zlotnik, A. and Sheiner, E. (2012) Acute Antepartum Pyelonephritis in Pregnancy: A Critical Analysis of Risk Factors and Outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology, 162, 24-27.[CrossRef] [PubMed]
[16] Ko, G.J., Ahn, S.Y., Kim, J.E., Cho, E.J., Lee, K., Kim, H.Y., et al. (2019) Clinical Predictors Implicated in the Incidence of Acute Pyelonephritis during the Antepartum Period: A Population-Based Cohort Study. Kidney and Blood Pressure Research, 45, 297-306.[CrossRef] [PubMed]
[17] Hill, J.B., Sheffield, J.S., McIntire, D.D. and Wendel, G.D. (2005) Acute Pyelonephritis in Pregnancy. Obstetrics & Gynecology, 105, 18-23.[CrossRef] [PubMed]
[18] Sheffield, J.S. and Cunningham, F.G. (2005) Urinary Tract Infection in Women. Obstetrics & Gynecology, 106, 1085-1092.[CrossRef] [PubMed]
[19] Cunningham, F.G., Morris, G.B. and Mickal, A. (1973) Acute Pyelonephritis of Pregnancy: A Clinical Review. Obstetrics & Gynecology, 42, 112-117.
[20] Labi, A., Yawson, A., Ganyaglo, G. and Newman, M. (2015) Prevalence and Associated Risk Factors of Asymptomatic Bacteriuria in Ante-Natal Clients in a Large Teaching Hospital in Ghana. Ghana Medical Journal, 49, 154-158.[CrossRef] [PubMed]
[21] Scholes, D., Hooton, T.M., Roberts, P.L., Gupta, K., Stapleton, A.E. and Stamm, W.E. (2005) Risk Factors Associated with Acute Pyelonephritis in Healthy Women. Annals of Internal Medicine, 142, 20‑27.[CrossRef] [PubMed]
[22] Fatton, B. (2004) Infections urinaires de la femme enceinte—Urinary Tract Infections in Pregnant Women.
[23] Bethel, J. (2012) Acute Pyelonephritis: Risk Factors, Diagnosis and Treatment. Nursing Standard, 27, 51-58.[CrossRef] [PubMed]
[24] Michel, C. (n.d.) Infections urinaires gravidiques: Analyse de leur prise en charge dans le service d’hospitalisation des grossesses du CHU Estaing à Clermont-Ferrand. 75.
[25] Zanatta, D.A.d.L., Rossini, M.d.M. and Trapani Júnior, A. (2017) Pyelonephritis in Pregnancy: Clinical and Laboratorial Aspects and Perinatal Results. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics, 39, 653-658.[CrossRef] [PubMed]
[26] Gilstrap, L.C., Cunningham, F.G. and Whalley, P.J. (1981) Acute Pyelonephritis in Pregnancy: An Anterospective Study. Obstetrics & Gynecology, 57, 409-413.
[27] Saleh, P., Noshad, H., Mallah, F. and Ramouz, A. (2015) Acute Pyelonephritis in Pregnancy and the Outcomes in Pregnant Patients. Archives of Clinical Infectious Diseases, 10, e28886.[CrossRef
[28] Se, G. (2008) Urinary Tract Infections in Patients with Diabetes Mellitus: Epidemiology, Pathogenesis and Treatment. International Journal of Antimicrobial Agents, 31, S54-S57.
https://pubmed.ncbi.nlm.nih.gov/18054467/
[29] Dalal, S., Nicolle, L., Marrs, C.F., Zhang, L., Harding, G. and Foxman, B. (2009) Long‐Term Escherichia coli Asymptomatic Bacteriuria among Women with Diabetes Mellitus. Clinical Infectious Diseases, 49, 491-497.[CrossRef] [PubMed]
[30] Arab, K., Spence, A.R., Czuzoj-Shulman, N. and Abenhaim, H.A. (2017) Pregnancy Outcomes in HIV-Positive Women: A Retrospective Cohort Study. Archives of Gynecology and Obstetrics, 295, 599-606.[CrossRef] [PubMed]
[31] Enwonwu, C. (2006) Complex Interactions between Malnutrition, Infection and Immunity: Relevance to HIV/AIDS Infection. Nigerian Journal of Clinical and Biomedical Research, 1, 6-14.
[32] Mazor-Dray, E., Levy, A., Schlaeffer, F. and Sheiner, E. (2009) Maternal Urinary Tract Infection: Is It Independently Associated with Adverse Pregnancy Outcome? The Journal of Maternal-Fetal & Neonatal Medicine, 22, 124-128.[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.